Similar articles

• Tumor-associated eosinophilotactic factor.

  Wasserman SI, Goetzl EJ, Ellman L, Austen KF. Wasserman SI, et al. N Engl J Med. 1974 Feb 21;290(8):420-4. doi: 10.1056/NEJM197402212900802. N Engl J Med. 1974. PMID: 4811016 No abstract available.
• Letter: Roles of the eosinophil.

  [No authors listed] [No authors listed] N Engl J Med. 1974 Apr 25;290(17):969-70. doi: 10.1056/NEJM197404252901715. N Engl J Med. 1974. PMID: 4816992 No abstract available.
• Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia.

  David JR, Vadas MA, Butterworth AE, de Brito PA, Carvalho EM, David RA, Bina JC, Andrade ZA. David JR, et al. N Engl J Med. 1980 Nov 13;303(20):1147-52. doi: 10.1056/NEJM198011133032004. N Engl J Med. 1980. PMID: 7421931
• [Eosinophils and their role in pathologic conditions].

  Rogala E, Rogala B. Rogala E, et al. Postepy Hig Med Dosw. 1988 Mar-Apr;42(2):224-34. Postepy Hig Med Dosw. 1988. PMID: 3076001 Review. Polish. No abstract available.
• The eosinophil, a cell with multiple facets.

  Capron M, Goldman M. Capron M, et al. Therapie. 2001 Jul-Aug;56(4):371-5. Therapie. 2001. PMID: 11677855 Review. No abstract available.